Business

Pfizer sees about $15 billion in 2021 sales from COVID-19 vaccine

Published by linker 5

Posted on February 2, 2021

1 min read

· Last updated: January 21, 2026

Add as preferred source on Google
Pfizer logo on building façade, representing COVID-19 vaccine sales forecast - Global Banking & Finance Review
The image features the Pfizer logo, symbolizing the company's forecast of $15 billion in sales from its COVID-19 vaccine. This relates to the significant financial impact of the vaccine on Pfizer's overall revenue in 2021.
Global Banking & Finance Awards 2026 — Call for Entries

(Reuters) – Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German partner BioNTech.

The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion.

(Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)

Related Articles

More from Business

Explore more articles in the Business category